ProTherax Ltd is pleased to announce that as of the 13 January 2012 we have become registered with the European Medicines Agency (EMA) as a Micro/Autonomous Regulatory Consultancy.
In line with EMA policy, ProTherax is now able to qualify for a range of incentives from EMA relating to the development of human pharmaceuticals.
These include:

• Administrative and procedural assistance from the SME Office at EMA
• Fee reductions of up to 90% for scientific advice and scientific services made on behalf of our non-EU clients
• Fee exemptions for certain administrative services of the Agency.

If you wish to take advantage of our SME status for European scientific advice, please contact us for a quotation today.

ProTherax Ltd is pleased to announce the publication of our new website, which is now viewable from all browsers, including mobile browsers. 

Please note that with immediate effect our office telephone number has changed. We now be contected on +44 1274 561815  

ProTherax Ltd is pleased to announce that we have become members of BIONOW, an organisation supporting the biomedical / life-sciences industry in the North of England. Bionow offers a range of specialist business support products and services such as procurement, insurance, recruitment, events and other specialist services such as business planning and consultancy. All are aimed at enabling the potential of biomedical businesses and making them more competitive by providing significant bottom line savings
.  More information on Bionow can be found at


ProTherax Ltd is pleased to report that a new testimonial relating to a recently completed project; a series of Clinical Evaluation Reports for medical devices from Class I non-sterile to Class IIb - sterile has been provided.  More details can be found by clicking here.